HumanaNYSE: HUM

NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Humana Inc. ("Humana" or the "Company") (NYSE: HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of October 31, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of October 31, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

HUM's third-quarter results benefit from higher-than-anticipated Medicare Advantage membership.

Humana Inc. (NYSE:HUM) will hold its Q3 2024 Earnings Conference Call on October 30, 2024, at 9:00 AM ET. The call will feature company representatives including Lisa Stoner, James Rechtin, Susan Diamond, and George Renaudin. Various analysts from firms like Wolfe Research, Mizuho, and Barclays will also participate in the call.

Humana (NYSE:HUM), a profit-driven health insurance company in the U.S., announced better-than-expected results for the third quarter, which boosted its stock prices on Wednesday. The company's revenue for Q3 reached $29.3 billion, exceeding predictions of $28.7 billion. Additionally, they raised their profit forecast for the entire year.

The financial results for Humana (HUM) provide an overview of the company's performance for the quarter ending in September 2024. It may be helpful to compare some important metrics with Wall Street predictions and figures from the same period last year.

The health insurance company still expects its adjusted earnings per share for the entire year to be at least $16.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) has shared its financial results for the quarter ending September 30, 2024 (3Q24) compared to the same quarter in 2023 (3Q23), as well as for the first nine months of 2024 (YTD 2024) against the same period in 2023 (YTD 2023). The details of their consolidated income before taxes and equity earnings are provided in the tables below. The figures are presented in millions.